Pre-operative Nomogram to Predict Risk of Peri-operative Mortality following Liver Resections for Malignancy

Journal of Gastrointestinal Surgery

Volumn 14, Issue 11, 2010, Pages 1770-1781

  Dhir, Mashaal ^a   Smith, Lynette M ^a   Ullrich, Fred ^a   Leiphrakpam, Premila D ^a   Ly, Quan P ^a   Sasson, Aaron R ^a   Are, Chandrakanth ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Liver resections; Malignancy; Nomogram; Peri operative mortality

Indexed keywords

AGED; ARTICLE; FEMALE; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; MORTALITY; NOMOGRAM; RISK ASSESSMENT; STATISTICAL MODEL;

AGED; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MODELS, STATISTICAL; NOMOGRAMS; RISK ASSESSMENT;

EID: 77958504043     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1352-2     Document Type: Article

References (34)

1. Dimick JB, Wainess RM, Cowan JA, Upchurch GR, Jr., Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004; 199: 31-8.
2. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406; discussion -7.
3. de Baere T, Denys A, Madoff DC. Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 2007; 10: 67-78.
4. Adam R, Miller R, Pitombo M, Wicherts DA, de Haas RJ, Bitsakou G, Aloia T. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 2007; 16: 525-36, viii.
5. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 2008; 195: 508-20.
6. Lencioni R, Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 2007; 10: 38-46.
7. Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 2003; 14 Suppl 2: ii13-6.
8. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008; 13: 51-64.
9. Vauthey JN, Zorzi D, Pawlik TM. Making unresectable hepatic colorectal metastases resectable-does it work? Semin Oncol 2005; 32: S118-22.
10. Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, Del Gaudio M, Pinna AD. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 2009; 249: 995-1002.
11. Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG, Khuri SF, Tanabe KK. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 2007; 204: 1284-92.
12. Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD, Pawlik TM. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 2008; 12: 842-51.
13. Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 1999; 134: 30-5.
14. Ston ME, Jr., Rehman SU, Conaway G, Sardi A. Hepatic resection at a community hospital. J Gastrointest Surg 2000; 4: 349-53; discussion 53-4.
15. Ra J, Paulson EC, Kucharczuk J, Armstrong K, Wirtalla C, Rapaport-Kelz R, Kaiser LR, Spitz FR. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol 2008; 15: 1577-84.
16. Simons JP, Hill JS, Ng SC, Shah SA, Zhou Z, Whalen GF, Tseng JF. Perioperative mortality for management of hepatic neoplasm: a simple risk score. Ann Surg 2009; 250: 929-34.
17. Simons JP, Ng SC, Hill JS, Shah SA, Bodnari A, Zhou Z, Tseng JF. In-hospital mortality for liver resection for metastases: a simple risk score. J Surg Res 2009; 156: 21-5.
18. Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF. In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer 2010; 116: 1733-8.
19. Are C, Afuh C, Ravipati L, Sasson A, Ullrich F, Smith L. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg 2009; 13: 2152-62.
20. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
21. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138: 1198-206; discussion 206.
22. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134: 984-92.
23. Yanaga K, Wakasugi K, Matsusaka T, Kume H. Hepatic resection without mortality at a community hospital. Int Surg 2003; 88: 87-91.
24. (No author's listed) Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000; 31: 840-5.
25. Green FL PD, Fleming ID et. al. American Joint Committee on Cancer. Liver (including intrahepatic bile ducts). In: Frederick L. Greene CMB, Daniel G. Haller, Monica Morrow. AJCC Cancer Staging Handbook, 6th ed. New York: Springer, 2002: 131-44.
26. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003; 38: 207-15.
27. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
28. Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg 2009; 13: 2268-75.
29. Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707-16.
30. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006; 243: 373-9.
31. Kattan MW. The many uses of cancer prediction tools. Semin Oncol 2010; 37: 20-2.
32. Kattan MW, Marasco J. What is a real nomogram? Semin Oncol 2010; 37: 23-6.
33. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.
34. Samuel D. MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game. J Hepatol 2009; 50: 836-8.